Browsing by Titles

Showing results 1 to 4 of 4

  • Yi, Jun-Koo
  • Park, Song
  • Ha, Jae-Jung
  • Kim, Dae-Hyun
  • Huang, Hai
  • Park, Si-Jun
  • Lee, Mee-Hyun
  • Ryoo, Zae-Young
  • Kim, Sung-Hyun
  • Kim, Myoung-Ok
  • 2020-10
  • Yi, Jun-Koo. (2020-10). Effects of Dimethyl Sulfoxide on the Pluripotency and Differentiation Capacity of Mouse Embryonic Stem Cells. Cellular Reprogramming, 22(5), 244–253. doi: 10.1089/cell.2020.0006
  • Mary Ann Liebert Inc.
  • View : 793
  • Download : 0
  • Zhang, Haibo
  • Yi, Jun-Koo
  • Huang, Hai
  • Park, Song
  • Park, Sijun
  • Kwon, Wookbong
  • Kim, Eungyung
  • Jang, Soyoung
  • Kim, Si-Yong
  • Choi, Seong-Kyoon
  • et al
  • 2021-05
  • Zhang, Haibo. (2021-05). Rhein Suppresses Colorectal Cancer Cell Growth by Inhibiting the mTOR Pathway In Vitro and In Vivo. Cancers, 13(9), 2176. doi: 10.3390/cancers13092176
  • Multidisciplinary Digital Publishing Institute (MDPI)
  • View : 325
  • Download : 0

Targeting  AKT  with  costunolide  suppresses the  growth  of  colorectal  cancer  cells  and induces  apoptosis  in  vitro  and  in  vivo

  • Huang, Hai
  • Park, Song
  • Zhang, Haibo
  • Park, Sujin
  • Kwon, Wookbong
  • Kim, Eungyung
  • Zhang, Xiujuan
  • Jang, Soyoung
  • Yoon, Duhak
  • Choi, Seong-Kyoon
  • et al
  • 2021-03
  • Huang, Hai. (2021-03). Targeting AKT with costunolide suppresses the growth of colorectal cancer cells and induces apoptosis in vitro and in vivo. Journal of Experimental & Clinical Cancer Research, 40(1), 114. doi: 10.1186/s13046-021-01895-w
  • BioMed Central Ltd
  • View : 505
  • Download : 93

ZNF507 affects TGF-β signaling via TGFBR1 and MAP3K8 activation in the progression of prostate cancer to an aggressive state

  • Kwon, Wookbong
  • Choi, Seong-Kyoon
  • Kim, Daehwan
  • Kim, Hyeon-Gyeom
  • Park, Jin-Kyu
  • Han, Jee Eun
  • Cho, Gil-Jae
  • Yun, Sungho
  • Yu, Wookyung
  • Han, Se-Hyeon
  • et al
  • 2021-09
  • Kwon, Wookbong. (2021-09). ZNF507 affects TGF-β signaling via TGFBR1 and MAP3K8 activation in the progression of prostate cancer to an aggressive state. Journal of Experimental & Clinical Cancer Research, 40(1). doi: 10.1186/s13046-021-02094-3
  • Springer Science and Business Media LLC
  • View : 535
  • Download : 158
1